Treatment outcomes of tuberculosis patients with diabetes mellitus in a secondary health facility in Lagos Nigeria.

Main Article Content

Foluke Ayeni
Bolajoko Aina
Olubukola Oyetunde
Olusola Adejumo

Abstract

Background: The presence of diabetes mellitus (DM) has been shown by a growing body of evidence to be a risk factor for tuberculosis (TB) and co-infected patients may show poor response to TB treatment as both diseases interact negatively.


Objectives: This study is aimed at determining associated factors and comparing the treatment outcomes of TB patients living with and without DM in a secondary care TB treatment facility in Lagos state, Nigeria.


Methods: A retrospective review of patients records above 18 years' enrolled between 1st January 2011 and 31st December 2012 in a secondary care TB treatment facility in Lagos state was carried out.


Results: A total of 424 records of TB patients were reviewed, out of which 36 (8.5%) had DM. Mean age of TBDM patients (50.0±12.8) was higher than for TB-only patients (34.1±13.8). Male: Female ratio of TBDM and TB only patients was comparable. All TBDM patients had pulmonary TB. Of these, proportion of smear negativity (72.2%) was significantly higher than TB only patients (34.9%, p <0.001). More TBDM patients (38.9%) compared to TB only patients (20.6%) had poor treatment outcomes (p = 0.012).


Conclusion: The prevalence of TBDM was substantial and it was associated with advanced age, smear negative sputum result and poor treatment outcomes. Concurrent management of both diseases should be considered to improve treatment outcomes.

Downloads

Download data is not yet available.

Article Details

How to Cite
Ayeni, F., Aina, B., Oyetunde , O., & Adejumo, O. (2023). Treatment outcomes of tuberculosis patients with diabetes mellitus in a secondary health facility in Lagos Nigeria. West African Journal of Pharmacy, 27(2), 111-119. https://doi.org/10.60787/wapcp-27-2-116
Section
Articles

How to Cite

Ayeni, F., Aina, B., Oyetunde , O., & Adejumo, O. (2023). Treatment outcomes of tuberculosis patients with diabetes mellitus in a secondary health facility in Lagos Nigeria. West African Journal of Pharmacy, 27(2), 111-119. https://doi.org/10.60787/wapcp-27-2-116

Share

References

Tuberculosis & Diabetes Factsheet. The growing threat of the double burden of diabetes andtuberculosis.

http://www.worlddiabetesfoundation.org/sites/default/files/TB-diabetes%20coepidemic%20fact%20sheet_March2014%20update.pdf 2014 (accessed 16.03.02).

World Health Organization, Global Tuberculosis Report, (2013) 1–98. doi:978 92 4 156450 2.

Baghaei, P., Marjani, M., Javanmard, P., Tabarsi, P., & Masjedi, MR. (2013). Diabetes mellitus and tuberculosis facts and controversies. Journal of Diabetes & Metabolic Disorders, 12(1), 1.

Jeon CY, Murray MB (2008) Diabetes mellitus increases the risk of active tuberculosis: A systematic review of 13 observational studies.

PLOS Medicine 5(7): e152. doi:10.1371

Alisjahbana B, Van Crevel R, Sahiratmadja E, Den Heijer M, Maya A, Istriana E, Danusantoso H, Ottenhoff TH, Nelwan RH, van der Meer JW

(2006): Diabetes mellitus is strongly associated with tuberculosis in Indonesia. International Journal of Tuberculosis and Lung Disease,

(6):696–700.

Pablos-Mendez A, Blustein J, Knirsch CA (1997): The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics.

American Journal of Public Health, 87(4):574–579.

Stevenson CR, Forouhi NG, Roglic G, Williams BG, Lauer JA, Dye C, Unwin N (2007). Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BioMed Central Public Health. 7, 234. doi:10.1186/1471-2458-7-234.

Ruslami R, Aarnoutse RE, Alisjahbana B, van der Ven AJ, Van Crevel R (2010): Implications of the global increase of diabetes for tuberculosis control and patient care. Tropical Medicine & International Health 2010,15(11):1289–1299.

Singla R, Khan N, Al-Sharif N, Ai-Sayegh MO, Shaikh MA, Osman MM (2006): Influence of diabetes on manifestations and treatment

outcome of pulmonary TB patients. International Journal of Tuberculosis and Lung Disease, 10(1):74–79

Restrepo BI, Camerlin AJ, Rahbar MH, Wang W, Restrepo MA, Zarate I, Mora-Guzman F, CrespoSolis JG, Briggs J, McCormick JB, Fisher-Hoch

SP(2011). Cross-sectional assessment reveals high diabetes prevalence among newly-diagnosed tuberculosis cases, Bulletin of the World Health Organization. 89:352–359. doi:10.2471/BLT.10.085738.

World Health Organization, Global Tuberculosis Report, (2015) 1-204. doi: 978 92 4 156505 9

Olayinka AO, Anthonia O, Yetunde K. (2013) Prevalence of diabetes mellitus in persons with tuberculosis in a tertiary health centre in Lagos

Nigeria. Indian Journal of Endocrinology and Metabolism;17:486-9

Whiting DR, Guariguata L, Weil C, Shaw J (2011). IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030,

Diabetes research and clinical practice 94, 311-321.

Niazi AK, Kalra S (2012). Diabetes and tuberculosis: a review of the role of optimal glycemic control, Journal of Diabetes & Metabolic Disorders. 11: 28. doi:10.1186/2251-6581-11-28.

Duangrithi D, Thanachartwet V, Desakorn V, Jitruckthai P, Phojanamongkolkij K, Rienthong S, Chuchottaworn C, Pitisuttithum P (2013). Impact of diabetes mellitus on clinical parameters and treatment outcomes of newly diagnosed pulmonary tuberculosis patients in Thailand.

International Journal of Clinical Practice67:1199–1209. doi:10.1111/ijcp.12215.

Wang CS, Yang CJ, Chen HC, Chuang SH, Chong IW, Hwang and Huang MS (2009). Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis. Epidemiology and Infection, 137, pp 203-210. doi:10.1017/S0950268808000782.

Dooley KE, Tang T, Golub JE, Dorman SE, Cronin W (2009). Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. American Journal of Tropical Medicine and Hygiene. 80:634–9. doi:19346391.

Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, Lönnroth K, Ottmani SE, Goonesekera SD, Murray MB (2011). The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BioMed Central Medicine. 9: 81. doi:10.1186/1741-7015-9-81.

Alisjahbana B, Sahiratmadja E, Nelwan EJ, Purwa AM, Ahmad Y, Ottenhoff THM, Nelwan RHH, Parwati I, Van der Meer JWM, Van Crevel R (2007). The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clinical Infectious

Diseases 45 428–35. doi:10.1086/519841.

Dooley KE, Chaisson RE (2009). Tuberculosis and diabetes mellitus: convergence of two epidemics. The Lancet Infectious Diseases 9:737–746.

Chua SS, Kok LC, Yusof FAM, Tang GH, Huey Lee, Efendie B, Paraidathathu T (2012). Pharmaceutical care issues identified by pharmacists in patients with diabetes, hypertension or hyperlipidaemia in primary care settings. BioMed Central Health Services Research 12:388

World Health Organization, Tuberculosis: Fact sheet N°104.http://www.who.int/mediacentre/factsheets/fs104/en/#, (2010) (accessed16.05.01).

Ogbera AO, Kapur A, Chinenye S, Fasanmade 0, Uloko A, Odeyemi K (2014). Undiagnosed diabetes mellitus in tuberculosis: A Lagos report. Indian Journal of Endocrinology and Metabolism. 18:475–9. doi:10.4103/2230-8210.137488.

WHO. 44th World Health Assembly: resolutions and decisions — resolution WHA44. 8 (WHA44/1991/REC/1). World Health Organization, Geneva; 1991.

Sulaiman SAS, Khan AH, Ahmad N, Iqubal MS, Muttalif AR, & Hassali MA (2013). Impact of diabetes mellitus on treatment outcomes of

tuberculosis patients in tertiary care setup. American Journal of the Medical Sciences. 345(4), 321-325. doi:10.1097/MAJ.0b013e318288f8f3.

Nissapatorn V1, Kuppusamy I, Jamaiah I, Fong MY, Rohela M, Anuar AK (2005). Tuberculosis in diabetic patients: a clinical perspective. Southeast Asian Journal of Tropical Medicine and Public Health. 36 Suppl 4 (2005) 213–220.

Morley JE (1998). The elderly type 2 diabetic patient: special considerations. Diabetic Medicine 15:41–46.

Yamagishi F, Sasaki Y, Yagi T, Yamatani H, Kuroda F, Shoda H (2000). Frequency of complication of diabetes mellitus in pulmonary tuberculosis. Kekkaku 75:435-7

Kim SJ, Hong YP, Lew WJ, Yang SC, Lee EG (1995). Incidence of pulmonary tuberculosis among diabetics. Tubercle and Lung Disease 76: 529-533.

Feleke Y, Abdulkadir J, Aderaye G (1999). Prevalence and clinical features of tuberculosis in Ethiopian diabetic patients. East African medical

journal 76: 361-364.

Sreeramareddy CT, Panduru KV, Verma SC, Joshi HS, Bates MN (2008). Comparison of pulmonary and extrapulmonary tuberculosis in Nepal- a hospital-based retrospective study. BioMed Central Infectious Diseases 7: 1–7. doi:10.1186/1471-2334-8-8.

Shetty N, Shemko M, Vaz M, D'Souza G (2006). An epidemiological evaluation of risk factors for tuberculosis in South India: a matched case control study. International Journal of Tuberculosis and Lung Disease. 10:80–86. doi:16466042.

Musellim B, Erturan S, Duman ES, Ongen G (2005). Comparison of extra-pulmonary and pulmonary tuberculosis cases: Factors influencing the site of reactivation. International Journal of Tuberculosis and Lung Disease 9:1220–1223.

Joshi N, Caputo GM, Weitekamp MR, Karchmer AW (1999). Infections in patients with diabetes mellitus. New England Journal of Medicine. 341: 1906-1912.